While the mechanisms through which breast cancer cells escape TGF-β mediated growth suppression are being pursued, we observed a consistent reduction in Smad2 protein in several human triple negative breast cancer cells relative to normal cells. This evidence concerns the gene SMAD2 and triple-negative breast carcinoma.